Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.01
+0.02 (0.40%)
At close: Oct 29, 2025, 4:00 PM EDT
4.990
-0.020 (-0.40%)
Pre-market: Oct 30, 2025, 8:46 AM EDT
Revenue by Product
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.